920 related articles for article (PubMed ID: 32746878)
1. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
Hong W; Xue M; Jiang J; Zhang Y; Gao X
J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
[TBL] [Abstract][Full Text] [Related]
3. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
Jiang Z; Yin J; Peng G; Long X
Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
[TBL] [Abstract][Full Text] [Related]
4. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer.
Luo YH; Yang YP; Chien CS; Yarmishyn AA; Adekunle Ishola A; Chien Y; Chen YM; Tsai PH; Lin TW; Wang ML; Chiou SH
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008490
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
[TBL] [Abstract][Full Text] [Related]
7. Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis.
Ning Z; Tian Y; Li Y; Zhao X; Zhang J; Wang C; Hu J; Shen H; Wu W
Anticancer Drugs; 2022 Jan; 33(1):61-74. PubMed ID: 34620741
[TBL] [Abstract][Full Text] [Related]
8. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
9. CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis.
Zhang N; Fan J; Deng Z
Anticancer Drugs; 2022 Jun; 33(5):437-447. PubMed ID: 35324518
[TBL] [Abstract][Full Text] [Related]
10. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
11. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
12. Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.
Lei J; Zhu J; Hui B; Jia C; Yan X; Jiang T; Wang X
Cancer Immunol Immunother; 2023 Jan; 72(1):101-124. PubMed ID: 35750765
[TBL] [Abstract][Full Text] [Related]
13. hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.
Li C; Zhang J; Yang X; Hu C; Chu T; Zhong R; Shen Y; Hu F; Pan F; Xu J; Lu J; Zheng X; Zhang H; Nie W; Han B; Zhang X
Cell Death Dis; 2021 Aug; 12(9):807. PubMed ID: 34433810
[TBL] [Abstract][Full Text] [Related]
14. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
15. CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.
Wang J; Zhang R; Lin Z; Zhang S; Chen Y; Tang J; Hong J; Zhou X; Zong Y; Xu Y; Meng R; Xu S; Liu L; Zhang T; Yang K; Dong X; Wu G
J Hematol Oncol; 2020 Jul; 13(1):99. PubMed ID: 32690037
[TBL] [Abstract][Full Text] [Related]
16. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.
Niu R; Li D; Chen J; Zhao W
Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024
[TBL] [Abstract][Full Text] [Related]
17. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
[TBL] [Abstract][Full Text] [Related]
18. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
Song HM; Meng D; Wang JP; Zhang XY
Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
[TBL] [Abstract][Full Text] [Related]
19. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
Wei D; Sun L; Feng W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.
Wei CY; Zhu MX; Lu NH; Liu JQ; Yang YW; Zhang Y; Shi YD; Feng ZH; Li JX; Qi FZ; Gu JY
Mol Cancer; 2020 May; 19(1):84. PubMed ID: 32381016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
